At week 26, LDL-C was reduced by 19.0% (-36.0% to -1.9%, p=.029) in the tirzepatide 15 mg group compared to placebo while it was reduced by 17.8% (-33.7% to -2.0%, p= 0.028) in the dulaglutide 1.5 mg group compared to placebo though differences between the 2 medications were not seen [60]
Integrated brain atlas for unbiased mapping of nervous system effects following liraglutide treatment
A program that asks for nothing is not
Oklahoma City patients receive structured, safe direction
For most people who dont have an insulin deficiency, the American Diabetes Association now recommends trying a GLP-1 receptor agonist before starting insulin
For complete information, including boxed warning, see Important Safety Information: Contact: [email protected] SOURCE Ro